We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

pSP72 Vector

Standard Cloning Vector Used to Transcribe RNA In Vitro

  • Versatile vector that can be used for standard cloning and in vitro transcription
  • SP6 and T7 RNA polymerase promoters flank the multiple cloning region
  • Multiple cloning site provides a convenient selection of restriction sites for cloning

Size

Catalog number selected: P2191

$ 102.00 Your price: Log In

Add to Helix
pSP72 Vector
20μg
$ 102.00
Your price: Log In

The pSP72 Vector is a standard cloning vector that can be used for transcription of RNA in vitro. The pSP72 Vector contains the SP6 and T7 RNA polymerase promoters flanking a unique multiple cloning region, which includes restriction sites for XhoI, PvuII, HindIII, SphI, PstI, SalI, AccI, XbaI, BamHI, SmaI, KpnI, SacI, EcoRI, ClaI, EcoRV and BglII. The pSP72 and pSP73 Vectors are essentially identical except for the orientation of the multiple cloning site region.

Reference

  1. Krieg, P.A. and Melton, D.A. (1987) Meth. Enzymol. 155, 397–415.
0298VA05_2A-W

pSP72 Vector GenBank® Accession Number X65332 and vector sequence text file.

Protocols

Specifications

What's in the box?

Item Part # Size

pSP72 Vector

P219A 1 x 20μg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Resources

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom